Inverse agonism at serotonin and cannabinoid receptors.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Progress in Molecular Biology and Translational Science

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S1877-1173(10)91001-6PMID 20691957
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis

  2010cited by this paper
• The future of endocannabinoid-oriented clinical research after CB1 antagonists

  2009cited by this paper
• Assessment of binding affinity to 5-hydroxytryptamine 2A (5-HT2A) receptor and inverse agonist activity of naftidrofuryl: comparison with those of sarpogrelate.

  2009cited by this paper
• Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis

  2009cited by this paper
• Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens.

  2009cited by this paper
• Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors.

  2009cited by this paper
• Functional selectivity of G protein-coupled receptor ligands : new opportunities for drug discovery

  2009cited by this paper
• Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists

  2009cited by this paper
• Expression and function of 5-HT7 receptors in smooth muscle preparations from equine duodenum, ileum, and pelvic flexure.

  2009cited by this paper
• In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist

  2009cited by this paper
• Opposing Roles for 5-HT2A and 5-HT2C Receptors in the Nucleus Accumbens on Inhibitory Response Control in the 5-Choice Serial Reaction Time Task

  2008cited by this paper
• Molecular biology of 5-HT receptors.

  2008cited by this paper
• Dissociable Effects of Selective 5-HT2A and 5-HT2C Receptor Antagonists on Serial Spatial Reversal Learning in Rats

  2008cited by this paper
• Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disorders

  2008cited by this paper
• Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.

  2008cited by this paper
• RNA editing of the serotonin 5HT2C receptor and its effects on cell signalling, pharmacology and brain function.

  2008cited by this paper
• A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model.

  2008cited by this paper
• Physiological and therapeutic relevance of constitutive activity of 5-HT 2A and 5-HT 2C receptors for the treatment of depression.

  2008cited by this paper
• Differential Regulation of the Mesoaccumbens Dopamine Circuit by Serotonin2C Receptors in the Ventral Tegmental Area and the Nucleus Accumbens: An In Vivo Microdialysis Study with Cocaine

  2008cited by this paper
• The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

  2008cited by this paper
• Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications.

  2008cited by this paper
• Aminopyrazine CB1 receptor inverse agonists.

  2008cited by this paper
• Inverse Agonist and Neutral Antagonist Actions of Antidepressants at Recombinant and Native 5-Hydroxytryptamine2C Receptors: Differential Modulation of Cell Surface Expression and Signal Transduction

  2008cited by this paper
• A Conservative, Single-Amino Acid Substitution in the Second Cytoplasmic Domain of the Human Serotonin2C Receptor Alters Both Ligand-Dependent and -Independent Receptor Signaling

  2008cited by this paper
• Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.

  2007cited by this paper
• ACP-103, a 5-Hydroxytryptamine 2A Receptor Inverse Agonist, Improves the Antipsychotic Efficacy and Side-Effect Profile of Haloperidol and Risperidone in Experimental Models

  2007cited by this paper
• Functional Selectivity and Classical Concepts of Quantitative Pharmacology

  2007cited by this paper
• Antiobesity Efficacy of a Novel Cannabinoid-1 Receptor Inverse Agonist, N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in Rodents

  2007cited by this paper
• Missing Links: Mechanisms of Protean Agonism

  2007cited by this paper
• Inverse agonism: from curiosity to accepted dogma, but is it clinically relevant?

  2007cited by this paper
• Protean Agonism at the Dopamine D2 Receptor: (S)-3-(3-Hydroxyphenyl)-N-propylpiperidine Is an Agonist for Activation of Go1 but an Antagonist/Inverse Agonist for Gi1,Gi2, and Gi3

  2007cited by this paper
• Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.

  2007cited by this paper
• Hemopressin is an inverse agonist of CB1 cannabinoid receptors

  2007cited by this paper
• A neutral CB1 receptor antagonist reduces weight gain in rat.

  2007cited by this paper
• 5-HT Receptor Regulation of Neurotransmitter Release

  2007cited by this paper
• Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties

  2007cited by this paper
• Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors.

  2007cited by this paper
• overweight: updated meta-analysis Long term pharmacotherapy for obesity and

  2007cited by this paper
• Serotonin2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction.

  2007cited by this paper
• Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.

  2006cited by this paper
• Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.

  2006cited by this paper
• Insulin sensitivity in people born pre-term, with low or very low birth weight and small for gestational age.

  2006cited by this paper
• The chemistry of endocannabinoids.

  2006cited by this paper
• Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

  2006cited by this paper
• Differential Effects of 5-Methyl-1-[[2-[(2-methyl-3-pyridyl)oxyl]-5-pyridyl]carbamoyl]-6-trifluoromethylindone (SB 243213) on 5-Hydroxytryptamine2C Receptor-Mediated Responses

  2006cited by this paper
• Region‐dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors

  2006cited by this paper
• Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor 'silent antagonist'.

  2006cited by this paper
• SB-236057-A: a selective 5-HT1B receptor inverse agonist.

  2006cited by this paper
• Clozapine and haloperidol differentially alter the constitutive activity of central serotonin2C receptors in vivo.

  2006cited by this paper
• Reanalysis of constitutively active rat and human 5-HT7(a) receptors in HEK-293F cells demonstrates lack of silent properties for reported neutral antagonists

  2006cited by this paper
• Biarylpyrazole inverse agonists at the cannabinoid CB1 receptor: importance of the C-3 carboxamide oxygen/lysine3.28(192) interaction.

  2006cited by this paper
• Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies.

  2005cited by this paper
• CB1 cannabinoid receptor‐mediated modulation of food intake in mice

  2005cited by this paper
• Effect of serotonin depletion on 5-HT2A-mediated learning in the rabbit: evidence for constitutive activity of the 5-HT2A receptor in vivo

  2005cited by this paper
• Inverse agonism and neutral antagonism at cannabinoid CB1 receptors.

  2005cited by this paper
• Differential Effects of the 5-Hydroxytryptamine (5-HT)1A Receptor Inverse Agonists Rec 27/0224 and Rec 27/0074 on Electrophysiological Responses to 5-HT1A Receptor Activation in Rat Dorsal Raphe Nucleus and Hippocampus in Vitro

  2005cited by this paper
• Stable expression of constitutively activated mutant h5HT6 and h5HT7 serotonin receptors: inverse agonist activity of antipsychotic drugs

  2005cited by this paper
• Focus on the three key enzymes hydrolysing endocannabinoids as new drug targets.

  2005cited by this paper
• Multiple Signaling States of G-Protein-Coupled Receptors

  2005cited by this paper
• Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors.

  2005cited by this paper
• Historical review: Negative efficacy and the constitutive activity of G-protein-coupled receptors.

  2005cited by this paper
• Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors.

  2004cited by this paper
• Desensitization of G protein-coupled receptors and neuronal functions.

  2004cited by this paper
• 5-HT2 receptors.

  2004cited by this paper
• Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice.

  2004cited by this paper
• Constitutive Activity of the Serotonin2C Receptor Inhibits In Vivo Dopamine Release in the Rat Striatum and Nucleus Accumbens

  2004cited by this paper
• 6"-Azidohex-2"-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist.

  2004cited by this paper
• Role of the serotonin 5-HT(2A) receptor in learning.

  2003cited by this paper
• h5‐HT1B receptor‐mediated constitutive Gαi3‐protein activation in stably transfected Chinese hamster ovary cells: an antibody capture assay reveals protean efficacy of 5‐HT

  2003cited by this paper
• Therapeutic potential of 5-HT2C receptor antagonists in the treatment of anxiety disorders.

  2003cited by this paper
• N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) interaction with LYS 3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptor.

  2002cited by this paper
• The human 5‐HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects

  2002cited by this paper
• Evidence for protean agonism of RX 831003 at α2A-adrenoceptors by co-expression with different Gα protein subunits

  2002cited by this paper
• Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. III. Agonist and Antagonist Properties at Serotonin, 5-HT1 and 5-HT2, Receptor Subtypes

  2002cited by this paper
• Enhanced detection of receptor constitutive activity in the presence of regulators of G protein signaling: applications to the detection and analysis of inverse agonists and low-efficacy partial agonists.

  2002cited by this paper
• G Protein-Coupled Receptor Allosterism and Complexing

  2002cited by this paper
• Apparent loss-of-function mutant GPCRs revealed as constitutively desensitized receptors.

  2002cited by this paper
• Considerations in the evaluation of inverse agonism and protean agonism at G protein-coupled receptors.

  2002cited by this paper
• Deramciclane (Egis).

  2002cited by this paper
• Constitutive activity of G-protein coupled receptors: emphasis on serotonin receptors.

  2002cited by this paper
• Evidence for a Model of Agonist-induced Activation of 5-Hydroxytryptamine 2A Serotonin Receptors That Involves the Disruption of a Strong Ionic Interaction between Helices 3 and 6* 210

  2002cited by this paper
• Could the 5-HT1B receptor inverse agonism affect learning consolidation?

  2001cited by this paper
• 5-hydroxytryptamine2A receptor inverse agonists as antipsychotics.

  2001cited by this paper
• Inverse, protean, and ligand‐selective agonism: matters of receptor conformation

  2001cited by this paper
• Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatment

  2001cited by this paper
• Constitutive activity at serotonin 5-HT1D receptors: detection by homologous GTPγS versus [35S]-GTPγS binding isotherms

  2001cited by this paper
• Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor.

  2001cited by this paper
• Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.

  2001cited by this paper
• Inverse Agonist Properties of Antipsychotic Agents at Cloned, Human (h) Serotonin (5-HT)1B and h5-HT1D Receptors

  2001cited by this paper
• Differential modulation by GTPγS of agonist and inverse agonist binding to h5‐HT1A receptors revealed by [3H]‐WAY100,635

  2001cited by this paper
• Agonist, antagonist, and inverse agonist properties of antipsychotics at human recombinant 5-HT(1A) receptors expressed in HeLa cells.

  2001cited by this paper
• SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety.

  2001cited by this paper
• RNA‐editing of the 5‐HT2C receptor alters agonist‐receptor‐effector coupling specificity

  2001cited by this paper
• The nigrostriatal dopamine system: a neglected target for 5-HT2C receptors.

  2001cited by this paper
• Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation.

  2001cited by this paper
• The putative <<silent>> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors.

  2000cited by this paper
• Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.

  2000cited by this paper
• Activation of Cannabinoid Receptors in Rat Brain by WIN 55212-2 Produces Coupling to Multiple G Protein α-Subunits with Different Potencies

  2000cited by this paper
• Dissociable effects of the 5-HT(2) antagonist mianserin on associative learning and performance in the rabbit.

  2000cited by this paper
• Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat

  2000cited by this paper

• Ligand-Free Signaling of G-Protein-Coupled Receptors: Physiology, Pharmacology, and Genetics

  2023cites this paper
• Ligand-Free Signaling of G-Protein-Coupled Receptors: Relevance to μ Opioid Receptors in Analgesia and Addiction

  2022cites this paper
• Functional approaches to the study of G-protein-coupled receptors in postmortem brain tissue: [35S]GTPγS binding assays combined with immunoprecipitation

  2021cites this paper
• Delta Opioid Receptor Inverse Agonists and Their in vivo Pharmacological Effects.

  2020cites this paper
• Should inverse agonists be defined by pharmacological mechanism or clinical effect?

  2019cites this paper
• Region-Resolved Quantitative Proteome Profiling Reveals Molecular Dynamics Associated With Chronic Pain in the PNS and Spinal Cord

  2018cites this paper
• Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine

  2017cites this paper
• Endothelial cell's response to proteostatic dysregulation: pursuing the protective action of ghrelin

  2016cites this paper
• Understanding the impact of 5-HTTLPR, antidepressants, and acute tryptophan depletion on brain activation during facial emotion processing: A review of the imaging literature.

  2016cites this paper
• Effects of CB1 receptor agonism and antagonism on behavioral fear and physiological stress responses in adult intact, ovariectomized, and estradiol-replaced female rats.

  2015cites this paper
• The involvement of medial septum 5-HT1 and 5-HT2 receptors on ACPA-induced memory consolidation deficit: Possible role of TRPC3, TRPC6 and TRPV2

  2015cites this paper
• CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.

  2013influential citation
• Serotonin2C receptors and drug addiction: focus on cocaine

  2013cites this paper
• Fitting the complexity of GPCRs modulation into simple hypotheses of ligand design.

  2012cites this paper
• 2012 Landes Bioscience. Do not distribute. Altered patterns of filopodia production in CHO cells heterologously expressing zebra finch CB 1 cannabinoid receptors

  2012cites this paper
• Altered patterns of filopodia production in CHO cells heterologously expressing zebra finch CB1 cannabinoid receptors

  2012cites this paper
• Circadian rhythms, melatonin and depression.

  2011cites this paper
• Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk

  2011cites this paper
• Cell type specificity in CB1 antagonism

  2011influential citation